Ghaith Abu-Zeinah

15PUBLICATIONS
103CO-AUTHORS
HaematologyGene and molecular therapyHaematological tumoursMedical microbiology not elsewhere classifiedRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 17, 2026
Cross-study analyses of the ropeginterferon alfa-2b effect on phlebotomy in low- and high-risk patients with polycythemia vera.

|Jun 24, 2026
Between the classic hit and the modern sequel: transition dosing between peginterferon alfa-2a and ropeginterferon alfa-2b for myeloproliferative neoplasms.

|May 22, 2026
Long-term outcomes of ropeginterferon alfa-2b-njft in polycythemia vera: a review of safety, efficacy, and potential disease modification.

|Apr 15, 2025
DNMT3A mutations are unlikely to affect interferon alfa treatment outcomes in patients with polycythemia vera.

Ghaith Abu-Zeinah, Katie Erdos, Neville Lee

|Dec 18, 2024
High pulmonary hypertension risk by echocardiogram shortens survival in polycythemia vera.

Alexander J Gazda, Di Pan, Katie Erdos

|Sep 07, 2024
JAK2V617F impairs lymphoid differentiation in myeloproliferative neoplasms.

Daniel C Choi, Nassima Messali, Narasimha Rao Uda

Pageof 3

Frequent Collaborators

7 joint publications

Joseph Michael Scandura

3 joint publications

Richard T Silver

2 joint publications

Daniel Choi

2 joint publications

Federico Itri